Skip to main content
Fig. 3 | Journal of Pharmaceutical Health Care and Sciences

Fig. 3

From: Long-term relationship between everolimus blood concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma: a prospective study

Fig. 3

Changes in blood concentration of everolimus before and after combination with concomitant drugs (carbamazepine, prednisolone, and lansoprazole). *Prednisolone was reduced from 10 mg/day to 5 mg/day at the same time as carbamazepine and lansoprazole termination, and was discontinued after 1 week

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us